Journal List > J Korean Ophthalmol Soc > v.52(1) > 1008941

Kim, Lee, Cho, and You: Clinical Aspect and Prognosis of Staphylococcus Epidermidis Keratitis

Abstract

Purpose

To investigate the predisposing factors, clinical manifestations, treatment results and risk factors for treatment failure in Staphylococcus epidermidis keratitis.

Methods

Sixty-one eyes of 61 patients who were diagnosed with Staphylococcus epidermidis keratitis were included in the present study. The past history, location and size of ulceration, hypopyon, treatment results, and antibiotic susceptibility were reviewed retrospectively. A logistic regression analysis was performed to identify the main prognostic risk factors for treatment failure.

Results

Twenty-six eyes (42.6%) had previous histories of corneal traumas. Polymicrobial infections were observed in 31 cases (50.8%), including 11 cases (35.5%) combined with the Fusarium species. Twenty-five eyes (41.0%) had lesions located at the corneal center. The average size of ulceration was 7.3 ± 7.2 mm2. Thirteen eyes (21.3%) with lesions that progressed or occurred in the corneal perforation underwent evisceration, penetrating keratoplasty or scleral graft. Risk factors for treatment failure were a history of previous keratitis (P = 0.003) and an ulcer exceeding 5.0 mm2 in size (P = 0.018).

Conclusions

Staphylococcus epidermidis keratitis usually has a good prognosis, although a history of previous keratitis and a large ulcer size are risk factors for treatment failure.

References

1. Lowy FD, Hammer SM. Staphylococcus epidermidis infections. Ann Intern Med. 1983; 99:834–9.
crossref
2. Tierno PM Jr, Stotzky G. Serologic typing of Staphylococcus epidermidis biotype 4. J Infect Dis. 1978; 137:514–23.
crossref
3. Fitzgerald RH Jr, Nolan DR, Ilstrup DM, et al. Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg Am. 1977; 59:847–55.
crossref
4. Karchmer AW, Archer GL, Dismukes WE. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med. 1983; 98:447–55.
crossref
5. Rubin J, Rogers WA, Taylor HM, et al. Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med. 1980; 92:7–13.
crossref
6. Bannerman TL, Rhoden DL, Mcallister SK, et al. The source of co-agulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol. 1997; 115:357–61.
7. Ormerod LD, Ho DD, Becker LE, et al. Endophthalmitis caused by the coagulase-negative staphylococci. Ophthalmology. 1993; 100:715–23.
crossref
8. Maske R, Hill JC, Oliver SP. Management of bacterial corneal ulcers. Br J Ophthalmol. 1986; 70:199–201.
crossref
9. Kunimoto DY, Sharma S, Garg P, et al. Corneal ulceration in the elderly in Hyderabad, south India. Br J Ophthalmol. 2000; 84:54–9.
crossref
10. Ammous MW, Noor Sunba MS. The nature of ulcerative keratitis in Kuwait (clinical and microbiological study). APMIS Suppl. 1988; 3:104–6.
11. Jang YS, Hahn YH. Epidemiology of Staphylococcus epidermidis keratitis. J Korean Ophthalmol Soc. 2002; 43:665–71.
12. Hahn YH, Hahn TW, Tchah HW, et al. Epidemiology of infectious keratitis (2): a multicenter study. J Korean Ophthalmol Soc. 2001; 42:247–65.
13. Lee KH, Chae HJ, Yoon KC. Analysis of risk factors for treatment failure in fungal keratitis. J Korean Ophthalmol Soc. 2008; 49:737–42.
crossref
14. Mukerji N, Vajpayee RB, Sharma N. Technique of area measurement of epithelial defects. Cornea. 2003; 22:549–51.
crossref
15. Khosla PK, Prakash OM, Agarwal LP. Clinicopathological study of soframycin in conjunctival flora. Orient Arch Ophthalmol. 1963; 1:212–20.
16. Thylefors JD, Harbarth S, Pittet D. Increasing bacteremia due to coagulase-negative staphylococci: fiction or reality? Infect Control Hosp Epidemiol. 1998; 19:581–9.
crossref
17. Tabbara KF, El-Sheikh HF, Aabed B. Extended wear contact lens related bacterial keratitis. Br J Ophthalmol. 2000; 84:327–8.
crossref
18. Vallas V, Stapleton F, Willcox MD. Bacterial invasion of corneal epithelial cells. Aust N Z J Ophthalmol. 1999; 27:228–30.
19. Rupp ME, Archer GL. Hemagglutination and adherence to plastic by Staphylococcus epidermidis. Infect Immun. 1992; 60:4322–7.
crossref
20. Ormerod LD, Hertzmark E, Gomez DS, et al. Epidemiology of microbial keratitis in southern California. A multivariate analysis. Ophthalmology. 1987; 94:1322–33.
21. Khan JA, Hoover D, Ide CH. Methicillin-resistant Staphylococcus epidermidis blepharitis. Am J Ophthalmol. 1984; 98:562–5.
crossref
22. Fleischer AB, Hoover DL, Khan JA, et al. Topical vancomycin formulation for methicillin-resistant Staphylococcus epidermidis blepharoconjunctivitis. Am J Ophthalmol. 1986; 101:283–7.
crossref
23. Sotozono C, Inagaki K, Fujita A, et al. Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea. Cornea. 2002; 21:S94–101.
crossref
24. Miedziak AI, Miller MR, Rapuano CJ, et al. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology. 1999; 106:1166–70.
crossref

Figure 1.
Age distribution of Staphylococcus epidermidis keratitis.
jkos-52-14f1.tif
Figure 2.
Seasonal variation of patients with Staphylococcus epidermidis keratitis.
jkos-52-14f2.tif
Figure 3.
(A) Anterior segment photograph of a 46-year-old woman, who had a history of corneal trauma at the first visit. Mild conjunctival injection and corneal infiltration were observed. The lesion was completely healed in 2 weeks with antimicrobial therapy. (B) Anterior segment photograph of an 89-year-old woman, who had a history of keratitis at a first visit. Slit-lamp examination revealed severe conjunctival injection, corneal lysis with a size of approximately 4 mm, hypopyon, corneal edema, folding of the Descemet's membrane. Staphylococcus epidermidis and Fusarium were isolated by corneal scraping. Despite of antimicrobial and antifungal therapy, patient's ocular condition deteriorated and evisceration was ultimately performed.
jkos-52-14f3.tif
Figure 4.
Visual acuities of the eyes with Staphylococcus epidermidis keratitis in the first and last medical examinations.
jkos-52-14f4.tif
Table 1.
Predisposing risk factors for Staphylococcus epidermidis keratitis
Cases Percentage (%)
Traumatism 26 42.6
Blepharitis 10 16.4
Previous keratitis 7 11.5
Previous PKP 5 8.2
Contact lens wear 3 4.9
Scleritis 2 3.3
Trichiasis 2 3.3
Dry eye syndrome 1 1.6
Unknown 5 8.2
Table 2.
Antibiotic susceptibility pattern of Staphylococcus epidermidis
Antibiotic susceptibility test (sensitive cases/tested cases) % (sensitive)
Penicillin-G 1/48 2.1
Ampicillin 3/13 23.1
Gentamicin 19/47 40.4
Oxacillin 25/61 41.0
Cefazolin 10/13 76.9
Clindamycin 46/61 75.4
Cephalothin 4/12 33.3
Erythromycin 36/61 59.0
Tetracycline 41/61 67.2
Tobramycin 19/26 73.1
Fosfomycin 21/26 80.8
Ciprofloxacin 46/61 75.4
Levofloxacin 26/33 78.8
Norfloxacin 21/33 63.6
Moxifloxacin 33/33 100.0
Teicoplanin 61/61 100.0
Vancomycin 61/61 100.0
Trimethoprim/Sulfamethoxazole 41/48 85.4
Rifampin 44/48 91.7
Table 3.
Clinical characteristics of 13 cases of Staphylococcus epidermidis keratitis with treatment failure
No Age Sex Predisposing factor & Systemic disease Coinfection Initial V/A (LogMAR) Location Depth Size (mm2) Hypopyon height (mm) Surgical Treatment
1 64 M Necrotizing scleritis Fusarium species 1.0 Peripheral Deep 4.4 None Evisceration
2 71 F Trauma (stone) Fusarium species 1.7 Central Deep 20.0 None Evisceration
3 49 M None Other coagulase-negative staphylococcus 2.5 Central Deep 16.8 1.5 Evisceration
4 54 M Trauma (plant) Streptococcus species, Other coagulase-negative staphylococcus 3.0 Central Deep 6.6 None Evisceration
5 82 F Corneal opacity due to herpetic keratitis None 2.75 Central Deep 16.0 None Scleral graft
6 63 M PKP after corneal laceration Enterobacter cloacae Fusarium species 3.0 Paracentral Deep 24.0 1.0 Evisceration
7 68 M Trauma (plant) Fusarium species 0.7 Paracentral Deep 4.0 1.0 Evisceration
8 68 M Diabetes Fusarium species 1.7 Central Deep 4.0 None PKP, Evisceration
9 88 F Hypertension None 2.75 Central Deep 10.2 1.3 Evisceration
10 54 M Previous keratitis None 2.0 Central Deep 12.0 None Scleral graft
11 70 M PKP due to previous keratitis Enterobacter cloacae Klebsiella pneumonia 1.7 Paracentral Deep 9.0 1.0 PKP, Evisceration
12 52 F Herpetic keratitis None 3.0 Central Deep 23.0 1.5 PKP
13 72 M PKP due to corneal opacity None 2.5 Central Deep 9.0 None PKP
Table 4.
Comparison of patients characteristics between treatment success and treatment failure group
Characteristics Treatment success group Treatment failure group P value
Age (yr) 56.39 ± 19.80 61.71 ± 9.84 0.179
Pretreatment symtoms duration (day) 3.30 ± 3.59 5.38 ± 4.93 0.001
Ulcer size (mm2) 5.93 ± 7.50 12.23 ± 7.09 0.037
Hypopyon height (mm) 0.98 ± 0.77 1.14 ± 0.24 0.586
Initial visual acuity (LogMAR) 1.26 ± 0.90 2.18 ± 0.77 0.023
Table 5.
Prognostic factors for treatment failure in Staphylococcus epidermidis keratitis
Variable No. of cases (n = 61) No. of treatment failure (n = 13) (%) Odds Ratio 95% CI P-value
Age (yr)
  >50 47 12 (25.53) 4.457 0.526–37.770 0.17
  ≤ 50 14 1 (7.14)
Gender
  Male 37 9 (24.32) 1.607 0.434–5.957 0.478
  Female 24 4 (16.67)
Visual acuity in the first exam (LogMAR)
  >1.0 40 11 (27.5) 3.603 0.717–18.097 0.12
  ≤ 1.0 21 2 (9.52)
Trauma
  Present 26 3 (11.54) 0.30 0.073–1.227 0.94
  Absent 35 10 (28.57)
Previous keratitis
  Present 13 6 (46.15) 8.167 2.042–32.654 0.003
  Absent 48 7 (14.58)
Systemic disease
  Present 14 4 (28.57) 2.708 0.715–10.259 0.143
  Absent 47 9 (19.15)
Location of ulcer
  Central or paracentral 46 12 (26.09) 4.941 0.586–41.697 0.142
  Peripheral 15 1 (6.67)
Size of ulcer (mm2)
  >5.0 28 10 (35.71) 5.556 1.348–22.901 0.018
  ≤ 5.0 33 3 (9.09)
Hypopyon
  Present 26 6 (23.28) 1.429 0.415–4.922 0.572
  Absent 35 7 (20.0)
Infiltration
  Deep 43 13 (30.23) 3.07 0.73–12.99 0.676
  Superficial 18 0 (0)
Coinfection
  Present 31 8 (25.8) 1.891 0.54–6.622 0.319
  Absent 30 5 (16.67)
Fusarium co-infection
  Present 11 5 (45.45) 3.125 0.809–12.064 0.098
  Absent 50 8 (16.0)
TOOLS
Similar articles